AUM
$458.6M
Estimated Dry Powder
$60.5M
Fund Size (Latest)
K-Bio Vaccine Fund
$67.1M
Estimated Cheque Size
$100K-$850K
Stages
- Seed
- Series A
- Series B
Fund Details
Year Established
2014
Website
https://www.dayli.partnersHQ
15th Floor, Aju Building,201 Teheran-ro, Gangnam-gu, Seoul, 06141, South Korea, Asia
HQ Phone
+82 (0)2 563 0890
About
Established in 2014, DAYLI Partners is a venture capital firm in South Korea. The firm specializes in venture investments in pharmaceutical, healthcare, and biotechnology sectors across South Korea.
HQ Map
No mappable locations available.
Locations
Tel: +82 (0)2 563 0890View map